Protections Against Employment, Housing, and Health Care Discrimination for People Living with or at High Risk of Acquiring HIV
Release date: March 15, 2022
Expiration date: March 15, 2023
Estimated time to complete activity: 0.75 hours
Jointly provided by Postgraduate Institute for Medicine and American Academy of HIV Medicine.
This activity is supported by an independent educational grant from Gilead Sciences, Janssen Therapeutics, and ViiV Healthcare.
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, pharmacists, and registered nurses; other healthcare providers, such as nutritionists, social workers, and case managers are also encouraged to attend.
Ronda B. Goldfein, Esq.
Executive Director, AIDS Law Project of Pennsylvania
Adrian Lowe, Esq.
Senior Staff Attorney, AIDS Law Project of Pennsylvania
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact house (0.75 APRN credit hours).
Type of Activity: Knowledge
Fee Information: There is no fee for this educational activity.
Method of Participation and Request for Credit
In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The planners and their spouses/partners wish to disclose they have no financial interests or other relationships with any ACCME-defined ineligible companies.
Ronda Goldfein has nothing to disclose.
Adrian Lowe has nothing to disclose.
Hardware and Software Requirements
This program requires the use of an internet-connected computer or device and a modern web browser capable of streaming video.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
If you have questions regarding the certification of this activity, please contact PIM via email at email@example.com.